Lead Selenide Quantum Dots | Safety Data Sheet (SDS)

SAFETY DATA SHEET

Date Accessed: 04/19/2024
Date Revised: 01/15/2022

SECTION 1. IDENTIFICATION

Product Name: Lead Selenide Quantum Dots

Product Number: All applicable American Elements product codes, e.g. PB-SE-01-QD

CAS #: 12069-00-0

Relevant identified uses of the substance: Scientific research and development

Supplier details:
American Elements
10884 Weyburn Ave.
Los Angeles, CA 90024
Tel: +1 310-208-0551
Fax: +1 310-208-0351

Emergency telephone number:
+1 800-424-9300


SECTION 2. HAZARDS IDENTIFICATION

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Acute toxicity, Oral(Category 3), H301
Acute toxicity, Inhalation(Category 3), H331
Carcinogenicity(Category 1B), H350
Reproductive toxicity(Category 1A), H360
Specific target organ toxicity -repeated exposure(Category 2), H373
Acute aquatic toxicity(Category 1), H400
Chronic aquatic toxicity(Category 1), H410
GHS Label elements, including precautionary statements
Pictogram

Skull and Crossbones - GHS06 Health Hazard - GHS08 Environment - GHS09

Signal word
Danger
Hazard statement(s)
H301 + H331
Toxic if swallowed or if inhaled
H350
May cause cancer.
H360
May damage fertility or the unborn child.
H373
May cause damage to organs through prolonged or repeated exposure.
H410
Very toxic to aquatic life with long lasting effects.
Precautionary statement(s)
P201
Obtain special instructions before use.
P202
Do not handle until all safety precautions have been read and understood.
P260
Do not breathe dust/ fume/ gas/ mist/ vapors/ spray.
P264
Wash skin thoroughly after handling.
P270
Do not eat, drink or smoke when using this product.
P271
Use only outdoors or in a well-ventilated area.
P273
Avoid release to the environment.
P280
Wear protective gloves/ protective clothing/ eye protection/ face protection.
P301 + P310 + P330
IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician. Rinse mouth.
P304 + P340 + P311
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor/ physician.
P308 + P313
IF exposed or concerned: Get medical advice/ attention.
P391
Collect spillage.
P403 + P233
Store in a well-ventilated place. Keep container tightly closed.
P405
Store locked up.
P501
Dispose of contents/ container to an approved waste disposal plant.
Hazards not otherwise classified (HNOC) or not covered by GHS-none


SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Substances
Formula: PbSe
Molecular weight: 286.16 g/mol
CAS-No.: 12069-00-0
EC-No.: 235-109-4


SECTION 4. FIRST AID MEASURES

Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2) and/or in section 11
Indication of any immediate medical attention and special treatment needed
No data available


SECTION 5. FIREFIGHTING MEASURES

Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Selenium/selenium oxides, Lead oxides
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available


SECTION 6. ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.


SECTION 7. HANDLING AND STORAGE

Precautions for safe handling
Further processing of solid materials may result in the formation of combustible dusts. The potential for combustible dust formation should be taken into consideration before additional processing occurs.
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.
Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Keep in a dry place.
Storage class (TRGS 510): Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
Specific end use(s)
Apart from the uses mentioned in section 1 no other specific uses are stipulate


SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.


SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Information on basic physical and chemical properties
Appearance
Form: powder
Color: gray
Odor
No data available
Odor Threshold
No data available
pH
No data available
Melting point/freezing point
No data available
Initial boiling point and boiling range
No data available
Flash point
No data available
Evaporation rate
No data available
Flammability (solid, gas)
No data available
Upper/lower flammability or explosive limits
No data available
Vapor pressure
No data available
Vapor density
No data available
Relative density
8.1 g/cm3 at 25 °C (77 °F)
Water solubility
No data available
Partition coefficient: n-octanol/water
No data available
Auto-ignition temperature
No data available
Decomposition temperature
No data available
Viscosity
No data available
Explosive properties
No data available
Oxidizing properties
No data available
Other safety information
No data available


SECTION 10. STABILITY AND REACTIVITY

Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products-No data available
In the event of fire: see section 5


SECTION 11. TOXICOLOGICAL INFORMATION

Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC:
3-Group 3: Not classifiable as to its carcinogenicity to humans(Lead(II) selenide)
2A-Group 2A: Probably carcinogenic to humans(Lead(II) selenide)
IARC:
3-Group 3: Not classifiable as to its carcinogenicity to humans(Lead(II) selenide)
2A-Group 2A: Probably carcinogenic to humans(Lead(II) selenide)
NTP:
Reasonably anticipated to be a human carcinogenThe reference note has been added by TD
based on the background information of the NTP.(Lead(II) selenide)
OSHA:
OSHA specifically regulated carcinogen(Lead(II) selenide)
Reproductive toxicity
Known human reproductive toxicant
No data available
Specific target organ toxicity -single exposure
No data available
Specific target organ toxicity -repeated exposure
May cause damage to organs through prolonged or repeated exposure.
Aspiration hazard
No data available
Additional Information
RTECS: Not available
Lead salts have been reported to cross the placenta and to induce embryo-and feto-mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported. Excessive exposure can affect blood, nervous, and digestive systems.
The synthesis of hemoglobin is inhibited and results in anemia. If left untreated, neuromuscular dysfunction, possible paralysis, and encephalopathy can result. Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., Acute selenium poisoning produces central nervous system effects, which include nervousness, convulsions, and drowsiness. Other signs of intoxication can include skin eruptions, lassitude,
gastrointestinal distress, teeth that are discolored or decayed, odorous ("garlic") breath, and partial loss of hair and nails. Chronic exposure by inhalation can produce symptoms that include pallor, coating of the tongue, anemia, irritation of the mucosa, lumbar pain, liver and spleen
damage, as well as any of the other previously mentioned symptoms. Chronic contact with selenium compounds may cause garlic odor of breath and sweat, dermatitis, and moderate emotional instability.
Stomach-Irregularities-Based on Human Evidence
Stomach-Irregularities-Based on Human Evidence


SECTION 12. ECOLOGICAL INFORMATION

Toxicity
No data available
Persistence and degradability:
No data available
Bioaccumulative potential:
No data available
Mobility in soil:
No data available
Results of PBT and vPvB assessment:
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
An environmental hazard cannot be excluded in the event of unprofessional handling or disposal.
Very toxic to aquatic life with long lasting effects.


SECTION 13. DISPOSAL CONSIDERATIONS

Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contact a licensed professional waste disposal service to dispose of this material.
Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.


SECTION 14. TRANSPORT INFORMATION

DOT (US)
UN number: 3283
Class: 6.1
Packing group: III
Proper shipping name: Selenium compound, solid, n.o.s.(Lead(II) selenide)
Reportable Quantity(RQ):
Marine pollutant: yes
Poison Inhalation Hazard: No
IMDG
UN number: 3283
Class: 6.1
Packing group: III
EMS-No: F-A, S-A
Proper shipping name: SELENIUM COMPOUND, SOLID, N.O.S.(Lead(II) selenide)
Marine pollutant: yes
IATA
UN number: 3283
Class: 6.1
Packing group: III
Proper shipping name: Selenium compound, solid, n.o.s.(Lead(II) selenide)


SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
The following components are subject to reporting levels established by SARA Title III, Section 313:
Lead(II) selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
Lead(II) selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
Pennsylvania Right To Know Components
Lead(II) selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
New Jersey Right To Know Components
Lead(II) selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
California Prop. 65 Components
WARNING! This product contains a chemical known to the State of California to cause cancer.
Lead(II) selenide
CAS-No.
12069-00-0
Revision Date
2007-09-28


SECTION 2. HAZARDS IDENTIFICATION

Classification of the substance or mixture
GHS
Classification in accordance with 29 CFR 1910 (OSHA HCS)
Flammable liquids (Category 2), H225
Acute toxicity, Oral (Category 3), H301
Acute toxicity, Inhalation (Category 3), H331
Carcinogenicity (Category 1B), H350
Carcinogenicity (Category 1A), H350
Reproductive toxicity (Category 1A), H360
Reproductive toxicity (Category 2), H361
Specific target organ toxicity -single exposure (Category 3), Central nervous system, H336
Specific target organ toxicity -repeated exposure (Category 2), H373
Aspiration hazard (Category 1), H304
Acute aquatic toxicity (Category 1), H400
Acute aquatic toxicity (Category 2), H401
Chronic aquatic toxicity (Category 1), H410
Chronic aquatic toxicity (Category 2), H411
GHS Label Elements:

Flame - GHS02 Exclamation Mark - GHS07 Health Hazard - GHS08

Signal Word: Danger
Hazardous Statements
H225
Highly flammable liquid and vapor.
H304
May be fatal if swallowed and enters airways.
H361
Suspected of damaging fertility or the unborn child.
H373
May cause damage to organs (Gastro-intestinal system, Liver, Immune) through prolonged or repeated exposure.
Precautionary Statements
P201
Obtain special instructions before use.
P202
Do not handle until all safety precautions have been read and understood.
P210
Keep away from heat/sparks/open flames/hot surfaces. No smoking.
P233
Keep container tightly closed.
P240
Ground/bond container and receiving equipment.
P241
Use explosion-proof electrical/ ventilating/ lighting/ equipment.
P242
Use only non-sparking tools.
P243
Take precautionary measures against static discharge.
P260
Do not breathe dust/ fume/ gas/ mist/ vapors/ spray.
P264
Wash skin thoroughly after handling.
P270
Do not eat, drink or smoke when using this product
P271
Use only outdoors or in a well-ventilated area.
P273
Avoid release to the environment.
P280
Wear protective gloves/ protective clothing/ eye protection/ face protection.
P301 + P310
IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician.
P303 + P361 + P353
IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower.
P304 + P340 + P312
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor/ physician if you feel unwell.
P308 + P313
IF exposed or concerned: Get medical advice/ attention.
P331
Do NOT induce vomiting.
P332 + P313
If skin irritation occurs: Get medical advice/ attention.
P362
Take off contaminated clothing and wash before reuse.
P370 + P378
In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish.
P391
Collect spillage.
P403 + P233
Store in a well-ventilated place. Keep container tightly closed.
P403 + P235
Store in a well-ventilated place. Keep cool.
P405
Store locked up.
P501
Dispose of contents/ container to an approved waste disposal plant.
Hazards not otherwise classified (HNOC) or not covered by GHS--none


SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Name: Lead Selenide Nanocrystals
Chemical Formula: PbSe
Typical Solvents (CAS No):
Toluene (108-88-3), Hexanes (110-54-3), Chloroform (67-66-3), Dichloromethane (75-09-2), Methanol (67-56-1), Water
Substance Name
PbSe
CAS #12069-00-0
Toluene
108-88-3
Oleic Acid
112-80-1


SECTION 4. FIRST AID MEASURES

Eye:
1. Flush immediately with warm water for at least 20 minutes
2. Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasionally lifting the upper and lower lids
3. If pain persists or recurs seek medical attention
4. Removal of contact lenses after an eye injury should only be undertaken by skilled personnel
Skin:
1. Removing contaminated clothing, shoes and leathery wearings
2. Washing affected area thoroughly with soap and water for at least 20 minutes
3. Call a physician if irritation develops or persists
Ingestion:
1. If spontaneous vomiting appears imminent or occurs, hold patient’s head down, lower than their hips to help avoid possible aspiration of vomits
2. If victim is conscious and alert, give 2-4 cupfuls of milk/water to dilute the substance in the stomach
3. Never give anything by mouth to an unconscious person
4. Don’t induce vomiting unless directed to by a medical person
5. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible, prior to initiating first aid procedures
6. Seek medical attention
Inhalation
1. Remove from further exposure and flush thoroughly with air
2. Lay patient down. Keep warm and rested
3. Prosthesis such as false teeth, which may block airway, should be removed, where possible, prior to initiating first aid procedures
4. If respiratory irritation seek immediate medical assistance and call a physician


SECTION 5. FIREFIGHTING MEASURES

Suitable extinguishing agents: Foam, CO2, dry chemical
Special Hazards:
1. Liquid and vapor are highly flammable
2. Severe fire hazard when exposed to heat, flame and/or oxidizers
3. Vapor may travel a considerable distance to source of ignition
4. Heating may cause expansion and or decomposition leading to violent rupture of containers
Protective equipment:
Wear self-contained respirator if necessary. Wear protective gloves.


SECTION 6. ACCIDENTAL RELEASE MEASURES

Person-related safety precautions:
Wear protective equipment. Keep unprotected persons away. Ensure adequate ventilation
Measures for environmental protection:
Do not allow material to be released to the environment without proper governmental permits.
Measures for cleaning/collecting:
1. Remove all ignition sources
2. Clean up all spills immediately
3. Avoid breathing vapors and contact with skin and eyes
4. Control personal contact by using protective equipment
5. Contain and absorb small quantities with vermiculite or other absorbent material
6. Wipe up
7. Collect residues in a flammable waste container


SECTION 7. HANDLING AND STORAGE

Precautions for safe handling:
1. Keep container tightly sealed. Store in refrigerator (2-8ºC) under dark conditions.
2. Wash thoroughly after handling
3. Use only in well ventilated area
4. Ground and bond containers when transferring
5. Use spark free tools and explosion proof equipment
Conditions for safe storage, including any incompatibilities
1. Keep container tightly sealed. Store in refrigerator (2-8ºC) under dark conditions.
2. Do not store with acids or oxidizers


SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Exposure Limit Lead Selenide:
TWA 0.2mg/mL air
Exposure for Toluene solvent
OSHA –Final PELs: 200ppm TWA
OSHA Ceiling: 300ppm
ACGIH: 50ppm, skin-potential for cutaneous absorption
NIOSH: 100ppm TWA: 375 mg/m3 TWA; 550ppm IDLH
Additional information about design of technical systems:
Properly operating chemical fume hood designed for hazardous chemicals and having an average face velocity of at least 100 feet per minute.
General protective and hygienic measures:
The usual precautionary measures for handling chemicals should be followed. Keep away from foodstuffs, beverages, and feed. Remove all soiled and contaminated clothing immediately. Wash hands before breaks and at the end of work. Avoid contact with the eyes and skin.
Breathing equipment:
Use suitable respirator when high concentrations are present.
Protection of hands:
Impervious gloves–check gloves using UV light after use to determine level of contamination.
Eye protection:
Safety glasses
Body protection:
Protective work clothing.


SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Form: Liquid form–black, dissolved in a solvent
Color: Black
Odor: Odor dependent upon solvent used. Crystalline powder is odorless
Melting point/Melting range: No data available
Boiling point/Boiling range: Determined by solvent used
Sublimation temperature / start: No data available
Flash point: Dependent upon solvent used
Ignition temperature: Dependent upon solvent used
Decomposition temperature: Not determined
Danger of explosion: Dependent upon solvent used.
Explosion limits: Currently unknown for nanocrystals
Vapor pressure: Dependent upon solvent used
Density: 8.0g/cm3
(crystal at 20 °C) for the nanocrystal powder if isolated
Solubility in / Miscibility with Polar Solvents: Soluble when hydrophilic ligands are present
Solubility in / Miscibility with Non-Polar Solvents: Soluble when hydrophobic ligands are present


SECTION 10. STABILITY AND REACTIVITY

Reactivity: Vapor is explosive when exposed to heat or flame
Stability: Stable at room temperature in closed containers under normal storage and handling conditions
Incompatible materials: Strong oxidizers
Hazardous decomposition products: Lead oxides, selenium oxides under fire conditions
Thermal decomposition / conditions to be avoided:
Not determined, but temperature increases will affect the solvent used.
Be aware of the necessary warnings for the specific solvent used.


SECTION 11. TOXICOLOGICAL INFORMATION

Skin: Irritant to skin and mucous membranes.
Eye: Irritating effect.
Sensitization: No sensitizing effects known.
Additional toxicological information: Danger through skin absorption.
To the best of our knowledge the acute and chronic toxicity of this substance is not fully known.
Target Organs: Lungs, Liver, Kidneys
EPA-B1:
Probable human carcinogen, limited evidence of carcinogenicity from epidemiologic studies.
IARC-1:
Carcinogenic to humans: sufficient evidence of carcinogenicity.
NTP-2:
Reasonably anticipated to be a carcinogen: limited evidence from studies in humans or sufficient evidence from studies in experimental animals. Carcinogen as defined by OSHA.
ACGIH A2:
Suspected human carcinogen: Agent is carcinogenic in experimental animals at dose levels, by route(s) of administration, at site(s), of histologic type(s), or by mechanism(s) considered relevant to worker exposure.
Available epidemiologic studies are conflicting or insufficient to confirm an increased risk of cancer in exposed humans.
Reproductive toxicity:Damage to fetus possible Suspected human reproductive toxicant.
Reproductive toxicity -Rat -Inhalation Paternal Effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count). Experiments have shown reproductive toxicity effects in male and female laboratory animals.
Developmental Toxicity:
Rat -Oral Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus)
Additional Information:
Lead salts have been reported to cross the placenta and to induce embryo-and feto-mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported. Excessive exposure can affect blood, nervous, and digestive systems. The synthesis of hemoglobin is inhibited and results in anemia. If left untreated,
neuromuscular dysfunction, possible paralysis, and encephalopathy can result. Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., Acute selenium poisoning produces central nervous system effects, which include nervousness,
convulsions, and drowsiness. Other signs of intoxication can include skin eruptions, lassitude, gastrointestinal distress, teeth that are discolored or decayed, odorous ("garlic") breath, and partial loss of hair and nails. Chronic exposure by inhalation can produce symptoms that include pallor, coating of the tongue, anemia, irritation of the mucosa, lumbar pain, liver and spleen damage, as well as any of the other previously mentioned symptoms. Chronic contact with selenium compounds may cause garlic odor of breath and sweat, dermatitis, and moderate emotional
instability.


SECTION 12. ECOLOGICAL INFORMATION

Do not allow material to be released to the environment without proper governmental permits.


SECTION 13. DISPOSAL CONSIDERATIONS

Consult local or national regulations for proper disposal.


SECTION 14. TRANSPORT INFORMATION

U.S. DOT 49 CFR 172.101
ID Number:
UN1294
Hazard class:
3
Packing Group:
II
Labeling Requirements:
Flammable Liquid
Canadian Transportation of Dangerous Goods:
UN1294, Class 3
Land Transport ADR/RID:
UN1294, Class 3, Class Code F1, Pack group II
Air Transport IATA/ICAO:
UN1294, Class or Division 3, Pack group II
Exceptions:
49 CFR 173.4
ID Number:
UN3283
Hazard class:
6
Packing Group:
III
Labeling Requirements:
Poison
Exceptions:
49 CFR 173.4


SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA\Title III, Section 302.
SARA 313 Components
The following components are subject to reporting levels established by SARA Title III, Section 313:
Toluene
CAS-No. 108-88-3
Revision Date 2007-07-01
Lead Selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
Massachusetts Right to Know Components
Toluene
CAS-No. 108-88-3
Revision Date
2007-07-01
Lead Selenide
CAS-No. 12069-00-0
Revision Date
1993-04-24
Pennsylvania Right to Know Components
Toluene
CAS-No. 108-88-3
Revision Date
2007-07-01
Lead Selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
New Jersey Right to Know Components
Toluene
CAS-No. 108-88-3
Revision Date
2007-07-01
Lead Selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
California Prop. 65 Components
WARNING:
This product contains a chemical known to the State of California to cause cancer.
Toluene
CAS-No. 108-88-3
Revision Date
2007-07-01
Lead Selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24
WARNING:
This product contains a chemical known to the State of California to cause birth defects or other
reproductive harm:
Toluene
CAS-No.
108-88-3
Revision Date
2007-07-01
Lead Selenide
CAS-No.
12069-00-0
Revision Date
1993-04-24